Discover2DocsToc040. Long COVID is More Common than You Think, with Dr. Keith Ellis
040. Long COVID is More Common than You Think, with Dr. Keith Ellis

040. Long COVID is More Common than You Think, with Dr. Keith Ellis

Update: 2024-12-23
Share

Description

If you're experiencing symptoms of long COVID, you're not alone. Learn more about this condition in this informative video.

Main Theme:
Dr. Ellis, a medicinal chemist, delves into the complexities of long COVID, focusing on its persistent symptoms and underlying causes, with a spotlight on innovative treatment approaches.

Understanding Long COVID:

A condition marked by prolonged symptoms such as fatigue and brain fog, affecting daily life for three to six months post-recovery.
Predominantly impacts women aged 30 to 65, leading to mental health challenges like depression and anxiety due to decreased physical activity.
Biological Mechanisms:

Role of platelet hyperactivation and microclots in contributing to serotonin depletion and mood disorders.
Microclots linked to COVID spike proteins potentially causing inflammation and impaired oxygen delivery, worsening fatigue and cognitive issues.
Challenges in Diagnosis and Treatment:

Patients often encounter difficulties with primary care physicians, leading to a cycle of referrals and symptomatic treatment.
Certain groups, such as those with preexisting immune issues and athletes, are more susceptible to long COVID.
Innovative Treatment Approaches:

A small study indicated an 80% recovery rate using a combination of apixaban and platelet inhibitors, though safety concerns exist.



Dr. Ellis suggests a natural supplement combining curcumin and white willow bark, designed to mimic anticoagulant effects and improve oxygen delivery.
Integration of Traditional and Modern Medicine:

Emphasis on combining traditional remedies with modern medicine to offer patient-focused solutions.
Highlighting CircuGuard as a potential over-the-counter option, with anecdotal evidence of effectiveness but lacking formal testing.
Research and Collaboration Challenges:

Noted difficulties in funding and collaboration for long COVID research.
Advocacy for recognizing and integrating traditional remedies when pharmaceutical solutions are limited.

Conclusion:
Dr. Ellis calls for a holistic approach to long COVID treatment, blending traditional knowledge with modern scientific advancements, and urges the medical community to focus on patient-centered care and innovative solutions.

Timestamps:
00:00 Introduction to Long COVID
02:06 Understanding Long COVID Symptoms
06:27 Demographics and Risk Factors
08:15 Dr. Ellis’s Journey into Long COVID Research
12:09 The Microclots Hypothesis
19:01 Current Treatments and Recommendations
23:34 Exploring MCAS and Immune Response
25:01 The Role of Microclots in Long COVID
29:07 Viral Reservoirs and Long COVID
30:52 Microclots: The Hidden Culprit
33:12 Innovative Approaches to Treatment
36:52 Creating a Safer Alternative
41:00 Patient Feedback and Effectiveness
46:34 The Future of Long COVID Research
49:54 Bridging Traditional and Modern Medicine


Petition for Continued Medicare Coverage for Rural Home Telehealth Visits Beyond 2024



GET IN TOUCH!
rob@2docstocpodcast.com
2docstoc.com
 @2DocsToc 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

040. Long COVID is More Common than You Think, with Dr. Keith Ellis

040. Long COVID is More Common than You Think, with Dr. Keith Ellis

Abbass Shafii, MD and Rob Hoyer, MD